Guangzhou LBP Medicine Science & Technology Co., Ltd. (SHA:688393)
28.90
-0.52 (-1.77%)
Jun 17, 2025, 2:45 PM CST
SHA:688393 Revenue
Guangzhou LBP Medicine Science & Technology had revenue of 72.54M CNY in the quarter ending March 31, 2025, a decrease of -28.51%. This brings the company's revenue in the last twelve months to 441.86M, down -13.02% year-over-year. In the year 2024, Guangzhou LBP Medicine Science & Technology had annual revenue of 470.79M, down -5.33%.
Revenue (ttm)
441.86M
Revenue Growth
-13.02%
P/S Ratio
6.23
Revenue / Employee
555.11K
Employees
796
Market Cap
2.75B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 470.79M | -26.50M | -5.33% |
Dec 31, 2023 | 497.29M | -10.09M | -1.99% |
Dec 31, 2022 | 507.38M | 68.39M | 15.58% |
Dec 31, 2021 | 438.99M | 63.56M | 16.93% |
Dec 31, 2020 | 375.43M | 20.27M | 5.71% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2013 | Pro | Pro | Pro |
Dec 31, 2012 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
WuXi AppTec | 39.59B |
Sichuan Biokin Pharmaceutical | 5.82B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Aier Eye Hospital Group | 21.81B |
Shanghai United Imaging Healthcare | 10.43B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |